News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Lisa A. Lacasse: American Cancer Society Cancer Action Network joined 79 other organizations supporting FDA rules to stop the sale of menthol cigarettes and all flavored cigars
Photo taken from Lisa Lacasse/LinkedIn
Nov 17, 2023, 17:53

Lisa A. Lacasse: American Cancer Society Cancer Action Network joined 79 other organizations supporting FDA rules to stop the sale of menthol cigarettes and all flavored cigars

Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post on LinkedIn:

“The American Cancer Society Cancer Action Network (ACS CAN) proudly joined 79 other organizations supporting FDA rules to stop the sale of menthol cigarettes and all flavored cigars. We’re urging the White House and OMB to expedite their review and issue final regulations by end of year. Once released this rule will also help combat the health disparities driven by Big Tobacco’s premeditated predatory practices to addict Black, LGBTQ and low-income communities for decades.”

Lisa A. Lacasse: American Cancer Society Cancer Action Network joined 79 other organizations supporting FDA rules to stop the sale of menthol cigarettes and all flavored cigars

Source: Lisa A. Lacasse/LinkedIn

American Cancer Society Cancer Action Network cancer FDA Lisa A. Lacasse OncoDaily Oncology
Special Coverage
Blog
Jan 23, 2025, 15:13
The 4th edition of Pediatric Radiation Oncology (Virtual) Course (PedROC 4.0) - The Dorcas Cancer Foundation
Blog
Jan 23, 2025, 15:02
Sachin H. Jain: The healthcare industry’s silent complicity in the face of massive dysfunction
Blog
Jan 23, 2025, 14:53
The PAINT Cancer Awareness and Hope event hosted by Cancer Fight Tanzania
Insight
Jan 23, 2025, 14:52
Debate Highlights Presented by Matti Aapro: Should All HR+/HER2- Metastatic Breast Cancer Patients Receive CDK4/6 Inhibitors in the First Line?
Insight
Jan 23, 2025, 14:43
Prof. Joseph Gligorov at BGICC 2025: Should All HR+/HER2- Metastatic Breast Cancer Patients Receive CDK4/6 Inhibitors in the First Line?
Blog
Jan 23, 2025, 14:43
AACR Forum on Exploring a New Generation of Patient-Centric Cancer Clinical Trials
Blog
Jan 23, 2025, 14:33
Elvina Almuradova: Improving Cancer Outcomes and Leadership Course
Science
Jan 23, 2025, 14:32
The EP3-ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Insight
Jan 23, 2025, 14:32
Transition metal complexes as an approach for targeting emerging cancer hallmarks - The Babak Lab
Blog
Jan 23, 2025, 14:32
Amer Zeidan: Insights from the Most Important MDS Studies at ASH24
Blog
Jan 23, 2025, 14:32
Sharron Moffatt: It shouldn’t take bravery to tell your boss you have cancer
Blog
Jan 23, 2025, 14:32
Erika Hamilton: A true team at Sarah Cannon Research Institute